Select Page

Lung Cancer News Update

Does Your Home Harbor a Killer?“HIGH POINT, N.C., Jan. 28, 2025 /PRNewswire/ — January is Radon Action Month, a vital time for individuals and communities to learn about radon risks and take action. This week, designated as National Radon Awareness Week by the...

Lung Cancer News Update

Protecting Medicaid for People with Lung Cancer“When Wynn first went to the hospital for a collapsed lung, she didn’t have health insurance and believed that she did not get the care she needed. Doctors did an x-ray and dealt with the immediate problem, but did not...

Lung Cancer News Update

Datopotamab Deruxtecan Granted Priority Review in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer “TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq:...

Lung Cancer News Update

J&J says its lung cancer drug combination keeps people alive longer“Key Points: Johnson & Johnson said a combination of its lung cancer drugs Rybrevant and Lazcluze kept people alive for at least a year longer than AstraZeneca’s Tagrisso in a clinical trial....

Lung Cancer News Update

Diabetes drug appears to fight lung cancer — but only in overweight or obese patients“Research conducted at Roswell Park Comprehensive Cancer Center has revealed that metformin also appears to fight lung cancer — but only in overweight or obese patients. Further,...

Lung Cancer News Update

Perioperative Pembrolizumab Regimen Upholds Survival Benefit in Resectable NSCLC“Key Takeaways: Pembrolizumab plus chemotherapy significantly improved 4-year OS and EFS in resectable early-stage NSCLC compared to chemotherapy alone. The pembrolizumab regimen showed a...